Keywords: taxol, first-line, choice, ovary, cancer, asco, study

Taxol First-Line Choice For Ovary Cancer: ASCO Study...

Article | 05 June 1995

Bristol-Myers Squibb's Taxol (paclitaxel) in combination with cisplatin represents the best first-line therapy for patients with advanced ovar-ian cancer, and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Paclitaxel

Taxol

Cyclophosphamide

Cytoxan

Cisplatin

Go to drug listing